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Abstract 
Background: Some rhythm disturbances may be detected on the surface 
electrocardiogram even during the neonatal period. Most of them are transitory and 
benign arrhythmias, others can constitute the first sign of cardiac disease or may 
become malignant and life-threatening. Furthermore, arrhythmogenic syndromes such 
as the Long QT syndrome and the Brugada syndrome can cause sudden death in 
infancy and may also contribute to SIDS (Sudden Infant Death Syndrome). The risk of 
fatal arrhythmias - which often manifest themselves in infancy, childhood or even at 
later age - justifies preventive measures. Since diagnosis in symptom-free patients 
requires electrocardiography, such a non invasive methodology must be available to 
provide early diagnosis and therapy. The Italian Ministry of Health has funded a 
prospective study in 50.000 neonates, involving 16 Italian centers, to assess the 
feasibility of a nationwide neonatal ECG screening. 
Aim: The purpose of this project was to assess prevalence and clinical significance of 
neonatal ECG abnormalities. This paper considers the data collected in Brindisi, at the 
“Perrino” Hospital, with the participation of ISBEM (Euro Mediterranean Scientific 
Biomedical Institute). 
Methods: From 2001 to 2006, electrocardiograms were recorded and the demographic 
data of newborns and of their parents were collected, as well as the clinical history of 
the newborn babies and of their mothers. All electrocardiographic parameters were 
measured according to the guidelines for the interpretation of the neonatal ECG. Data 
of all newborns enlisted in the study were entered into the neonatal ECG database. 
Newborns with clinically relevant ECG abnormalities were followed-up, according to the 
guidelines work-up section for clinical management of pathologies related to ECG 
anomalies. 
Results: Of the 2619 ECGs recorded, 418 (16%) presented abnormalities. Among the 
abnormalities 5 (0.2%) had a major clinical significance such as prolonged QT 
syndrome, Wolff-Parkinson-White syndrome and congenital heart disease.  
Conclusions: Although life-threatening arrhythmias are rare in infants, they are very 
serious and must be sought to avoid both short- and long-term morbidity and mortality. 
The electrocardiographic screening for neonates, as an additional measure of 
prevention, especially for the early identification of infants at risk of life-threatening 
arrhythmias, is available and relatively at low cost, and can also help detecting complex 
cardiac malformations. 
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Introduction 
Some rhythm disturbances (arrhythmias) may be detected on the surface 
electrocardiogram (ECG) even during the neonatal period. Cardiac arrhythmias 
are difficult to define epidemiologically, therefore there are limited data on their 
prevalence [1]. It is widely recognized that pediatric patients commonly 
experience arrhythmias both early and late after cardiac surgical procedures [2]. 
Hospital based studies provide a more accurate assessment of arrhythmias, but 
it is difficult to apply this information to the general population, as not all 
arrhythmias require hospitalization either because they are short-lived or 
asymptomatic. Arrhythmias are found in 1% to 5% of newborns during the first 
10 days of life. Most are premature supraventricular beats that will disappear 
over the first month of life [3]. On the other hand, there are some arrhythmias 
that can constitute the first sign of cardiac disease, or they can become 
malignant and life-threatening. Many congenital heart diseases and acquired 
cardiac diseases, such as myocarditis or cardiomyopathy, are associated with 
the occurrence of rhythm disturbances [4-6]. Over the past decade, molecular 
genetic research has established a link between a number of inherited lethal 
cardiac arrhythmias and mutations in genes encoding for ion channels or other 
membrane components. Among these inherited cardiac arrhythmias there are 
the congenital and acquired long QT syndrome (LQTS) [7,8] and the Brugada 
syndrome [9]. These arrhythmogenic syndromes pass unnoticed because they 
occur in children or young individuals completely asymptomatic and assumingly 
healthy, who can conduct a normal life. They are often diagnosed only after the 
appearance of the first symptoms. Long QT syndrome is characterized by the 
occurrence of syncopal episodes and by a high risk of sudden cardiac death 
among untreated patients due to a particular type of ventricular tachycardia, 
also known as torsades de pointes. In 12% of patients with LQTS, sudden 
death was the first manifestation of the disease, whilst in 4% this happened in 
the first year of life [10]. Results of a prospective study in 34,000 newborn 
babies showed that 50% of children, who died from Sudden Infant Death 
Syndrome (SIDS), had a QTc interval on ECG that was higher than normal and 
that a prolonged QT interval increased the risk of SIDS by 41 times [11]. Also 
with regard to the Brugada syndrome there exist documented cases of 
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malignant arrhythmias in babies of few months of life [12,13]. Such 
arrhythmogenic disorders of genetic origin, that can cause sudden death in 
infancy and also contribute to SIDS, are identifiable by ECG and molecular 
screening. The risk of fatal arrhythmias which often shows in infancy, childhood 
or even later justifies preventive measures. Since diagnosis in symptom-free 
patients requires electrocardiography, such non invasive methodology must be 
available, so as to provide early diagnosis and therapy.  
On the basis of different studies on this subject, the Italian Ministry of Health 
has suggested offering, free of charge, electrocardiographic screening to all 
newborns [14], as part of a cardiovascular screening program. Moreover, it has 
funded a prospective study in 50.000 newborns (more or less 10% of the births 
that occur in Italy every year) to assess the feasibility of a nationwide neonatal 
ECG screening. The project, under the scientific direction of Peter J. Schwartz, 
has involved 16 Italian centers. 
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Aim 
The purpose of the multi-center project ”Prospective study on prevalence, 
clinical significance and time-course of neonatal ECG abnormalities associated 
with arrhythmias during infancy” was to assess prevalence and clinical 
significance of neonatal ECG abnormalities, but also to appraise if an ECG 
done in neonatal age (15-25 days of life) can contribute to the prevention of 
Sudden Infant Death Syndrome (SIDS), as well as to an early diagnosis of 
Multiple Cardiac Morbid Disorders and to somehow pave the way to potential 
treatments. Such disorders include: cardiac arrhythmias, Wolff-Parkinson-White 
syndrome, some forms of congenital heart disease not yet clinically evident, 
Brugada syndrome, QT prolongation of unknown origin but potentially 
associated with increased risk of fatal arrhythmias, and long QT syndrome.  
This paper considers the data collected in Brindisi, at the “Perrino” Hospital, 
with the participation of ISBEM (Euro Mediterranean Scientific Biomedical 
Institute). 
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ECG and Arrhythmia  
The contraction (depolarization) and relaxation (repolarization) of the heart 
muscle is caused by a flow of electrolytes (sodium, potassium, and calcium) in 
and out of each heart muscle cell through the surrounding membrane. This flow 
generates a weak electrical current. Through an amplifier (the 
electrocardiograph) capable of picking up this weak current from the surface of 
the body, it is possible to record the electrical potential generated by the heart 
muscle cells during each heartbeat. This electrical potential displayed 
continuously on a roll of graph paper, is the standard electrocardiogram (ECG). 
It consists of 12 leads recorded with electrodes placed on various points on the 
chest, both arms, and the left leg, thus providing electrical "views" of the heart 
from various angles (fig. 1). Any deviation from the horizontal line, or baseline, 
whether above (positive potential) or below (negative potential), denotes 
electrical activity. Each change of potential is called a wave [15]. The normal 
electrocardiogram shows a sequence of evenly spaced complexes produced by 
each heartbeat. The electrical activity, that triggers each heartbeat, begins in 
the atria and then travels into the ventricles. It starts in the sino-atrial node, the 
heart’s natural pacemaker, which is localized in the upper part of the right 
atrium, and it is conveyed to all atrial myocytes, leading to coordinated 
depolarization and contraction of the atria. On the ECG, atrial depolarization 
can be visualized as a P wave. The electrical activity of the pacemaker is also 
conveyed to specialized cells that connect the atria and the ventricles, known as 
the atrio-ventricular node [16]. From there, it is transmitted to the ventricles via 
specialized fibers known as the bundle of His, which is subdivided into the right 
and left bundle and which runs along the right and the left side of the 
interventricular septum, respectively. Each of the bundle branches has many 
bifurcations, which finally create the Purkinje fibers network [17] leading to the 
rapid depolarization of all ventricular myocytes and to the coordinated 
contraction of the ventricles. Depolarization of the ventricles can be visualized 
on the ECG as the QRS complex. Ventricular myocytes then slowly repolarize - 
on the ECG this is denoted as the T wave - thus leading to cardiac relaxation 
and completion of one cardiac cycle [16] (fig. 2). The healthy heart has a regular 
sequence of action. The regularity of the heartbeat, its rate, and the origin and 
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spread of impulses can all deviate from normality. These abnormalities are 
called arrhythmia, or disturbance of the heart rhythm. The term is used even if 
the rhythm, or regular sequence of beats, is undisturbed, but the rate is too slow 
or too fast (bradycardia, tachycardia) [15]. In general, the abnormality that 
causes an arrhythmia may be one of the following: 1) abnormal function of the 
cells in the sinoatrial node, such that these cells are either not firing or not 
transmitting impulses properly; 2) delayed or improperly produced/conducted 
impulses through the atrioventricular node (which could cause heart block) or 
through the ventricles (which could cause bundle branch block); 3) an extra 
pathway in the conduction system, causing additional heartbeats; 4) electrical 
impulses arising from places in the heart other than the sinoatrial node. 
Furthermore, there are a number of heart-related factors associated with 
arrhythmias, including: congenital heart disease; arrhythmogenic syndrome 
(e.g., long QT syndrome, Brugada syndrome); abnormalities of the heart 
structure or function (cardiomyopathy, valvular heart disease); side effects from 
medications. The electrocardiogram is the principal tool for diagnosing cardiac 
arrhythmias, as it shows the rate and regularity of heartbeats; the shape, 
direction, and relationship of the waves to the other complexes, including the 
absence of waves; and deviations in the contour of the complexes and waves in 
the abnormally spaced beats. An equally important role of the 
electrocardiogram is that to provide information concerning the state of the 
heart muscle on the basis of certain alterations in the electrocardiographic 
complexes. However, this feature of the electrocardiogram requires more 
cautious interpretation because the alterations produced by changes in the 
heart muscle are less specific than those produced by arrhythmias. Experience 
has established the limits of normal variation in the height and direction of the 
waves and the baseline segments among them, in healthy persons according to 
age group [15].  
 
The normal neonatal ECG 
Growth and development result in major changes of body size and shape, and 
at the same time in the changes of size and position of the heart relative to the 
body and cardiac physiology [18]. These changes eventually lead to the 
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variability of findings of normal ECGs in children. The normal infant ECG varies 
rapidly over the first few weeks of life. At 3 years of age it begins to resemble 
characteristics of an adult. Significant differences, however, persist [18]. There 
are many normal variables with a wide overlap from normal to abnormal. The 
less than 35 week gestation premature infant will have a different ECG from the 
full term infant [19]. In order to interpret pediatric electrocardiograms, the age of 
the infant and a table of normal values are essential [18]. Normal 
electrocardiographic values between the 2nd and 98th percentile in the first 
year of life traditionally derive from those published by Davignon et al. [20] (see 
appendix ). 
 
Heart rate  
In children, cardiac output is determined primarily by heart rate, as opposed to 
stroke volume. With age, the heart rate decreases as the ventricles mature and 
stroke volume plays a larger role in cardiac output. The average resting heart 
rate varies with age: it increases from the first day of life and peaks between the 
first and the second month, then declines, returning at the sixth month to the 
values recorded at birth. After one year of age, due to maturation of the sinus 
node vagal innervation, it slowly declines [21]. The heartbeats of newborns can 
range from 90 to 160 beats per minute (bpm), without clinically significant 
gender differences.  
 
P wave 
The P wave represents depolarization of the two atria. It is generally pointed in 
lead II and aVF and more rounded in other leads, and may be diphasic in V1. 
The location of the P wave axis indicates the site of origin of the rhythm.  
 
PR interval  
The PR interval, measured in lead II from the onset of the P wave to the 
beginning of the QRS, corresponds to the time in which electrical impulses 
travel through the atria and the atrio-ventricular node. Here, the electrical 
activity will be delayed for a few milliseconds, giving the atria time to pump 
blood into the ventricles [16]. The PR interval, increases with age and 
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decreases with heart rate. The normal neonatal PR interval ranges from a 
minimum of 70 ms to a maximum of 140 ms, with a mean of 100 ms [19]. 
 
QRS complex  
Three waves together constitute the QRS complex. This complex shows 
depolarization of the two ventricles and coincides with the onset of ventricular 
contraction. QRS morphology in the newborn may have more notches and 
direction changes than seen in older children or adults [19]. In utero, blood is 
shunted away from the lungs by the patent ductus arteriosus, and the right 
ventricle provides most of the systemic blood flow. As a result, the right ventricle 
is the dominant chamber in the newborn infant. In the neonate and young infant 
(up to 2 months), the ECG shows right ventricular dominance and right QRS 
axis deviation. In a normal full-term newborn a QRS axis between 55° and 200° 
is a normal finding, with upper limit that falls to 160° or less by 1 month. If right 
axis deviation is seen in normal neonates, instead left axis deviation is seen in a 
variety of abnormalities including atrioventricular septal defect, ventricular septal 
defect, tricuspid atresia, and WPW syndrome. 
The first wave of the complex, small and negative, called Q wave, indicates the 
direction of septal depolarization in the precordial leads. Normally, there is a Q 
wave in leads V5–V6 indicating depolarization from left to right. Normal values 
of Q wave amplitudes vary with lead and age. Q wave duration >30 ms is 
abnormal. The second one is the tall and positive R wave. The appearance of 
secondary r waves (r’ or R’) in the right chest leads is frequent in normal 
neonates. Thomaidis et al. published normal voltages from healthy term and 
premature neonates [22]. The S wave is the last of the complex; it is negative 
during the first year of life and has elevated amplitude in left leads. The total 
amplitude of R+S in each limb lead ≤ 0.5 mV may be indicative of myocarditis or 
cardiomyopathy [19]. In the following years the Q wave does not show 
substantial modifications, whereas the amplitude of R wave progressively 
reduces in the right precordial leads and increases in the left precordial leads, 
and opposite modifications are shown by the S wave. Such changes are due to 
the progressive reduction of the right ventricular mass and to the relative 
increase of the left ventricular mass. QRS duration, from the beginning of the Q 
wave to the end of the S wave, increases with age, in neonate it measures 30-
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80 ms. A QRS duration exceeding 80 ms in newborn and infant may indicate 
delayed intraventricular activation, while QRS duration ≥ 120ms is called bundle 
branch block [23].  
 
T wave 
The T wave expresses the recovery of the excitability of the ventricular 
myocytes. In the first week of life this wave is normally rather variable. After the 
first week of life through the age of 8 years, T waves are usually inverted in 
leads V1 through V3 and positive in V5–V6, as the so called “juvenile T-wave 
pattern”. T wave positive in V1 and V2 leads during childhood can be a sign of 
systolic overload of the right ventricle, as seen in right ventricular hypertrophy; 
inverted T wave in V4-V6 indicates left ventricle suffering and is found in aortic 
stenosis [23]. 
 
ST segment  
The ST segment is isoelectric and joins the QRS complex to the T wave at the 
baseline (or slightly above or below the baseline). This segment shows the 
beginning of ventricular repolarization. In neonates and infants it is better to 
consider as the isoelectric line the TP segment instead of the PQ segment [19], 
because the Q portion of the QRS complex is frequently indiscernible. ST 
segment elevation in infancy has several causes, the most frequent is 
pericarditis. Less frequent causes of ST segment elevation, with or without T 
wave abnormalities are hyperkalaemia, intracranial hemorrhage, pneumothorax 
and pneumopericardium, subepicardial injury due to anomalous left coronary 
artery or to Kawasaki disease with cardiac involvement. ST segment elevation 
with other ECG features is also seen in the Brugada syndrome. 
 
QT interval 
The QT interval on ECG, between the beginning of the QRS complex and the 
end of the T wave, represents the time from onset of depolarization to fulfill of 
repolarization. Due to the fast heart rate of infants the P wave may be 
superimposed on the T wave, particularly when the QT interval is prolonged. 
The QT interval duration changes with heart rate and is usually corrected. The 
Bazett formula is the most commonly used manual method to measure the 
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corrected QT interval (QTc) [24]. This equation accounts for the normal 
physiologic shortening of the QT interval that occurs with increasing heart rate. 
The mean QTc on the 4th day of life is 400 ± 20 ms [11] and, at variance with 
the adult, no gender differences are present [25]. Therefore, the upper normal 
limit of QTc (2 standard deviations above the mean, corresponding to the 97.5 
percentile) is 440 ms. By definition, 2.5% of normal newborns are expected to 
have a QTc greater than 440 ms [19]. In healthy infants there is a physiological 
prolongation of QTc by the second month (mean 410 ms), followed by a 
progressive decline [26], so that by the sixth month QTc returns to the values 
recorded in the first week. QT interval prolongation may often be caused by 
electrolyte imbalance: hypocalcaemia increases the ST segment length, instead 
hypokalaemia and hypomagnesaemia usually decrease T wave amplitude. Also 
the use of widespread drugs during the neonatal period or infancy, as macrolide 
[27], antibiotics or prokinetics, may induce QT interval prolongation, as these 
block the channel of ionic current involved in the control of ventricular 
repolarization. Transient QT interval prolongation is found in babies positive for 
the anti-Ro/SSA antibodies from mothers with autoimmune diseases. 
Prolongation disappears concomitantly with the disappearance of the anti 
Ro/SSA antibodies. Central nervous system abnormalities can produce QT 
prolongation and T wave inversion. Moreover QT interval prolongation may 
indicate the congenital LQTS. 
 
The abnormal neonatal ECG 
Heart rate  
A sinus rhythm with a heart rate above or below the normal limit for age is 
defined respectively sinus tachycardia and sinus bradycardia. There are several 
causes of non-cardiac origin associated with sinus tachycardia and bradycardia. 
Autonomic nervous system dysfunction with vagal overactivity in infants may 
provoke sinus bradycardia and even significant sinus pauses. Sinus pauses 
produce electrical pauses in the rhythm. These may last 800-1000 ms. Pauses 
greater than 2 s are abnormal. Escape beats from atria or AV-junction may 
follow sinus pauses. Junctional escape rhythms occur when the atrial rate slows 
to the point where the AV node automaticity takes over. Apparent life-
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threatening events (ALTE) have been associated to sinus pauses and sudden 
bradycardia. These events have also been described in infants affected by Long 
QT syndrome, an arrhythmogenic syndrome which is evident in the neonatal 
period [28]. Slow heart rates may predispose to certain tachyarrhythmias, such 
as atrial flutter [29]. Neonates show a more regular rhythm than young children 
and adolescents, due to their fast heart rate, particularly in the first week of life. 
No pathologic features are associated with wandering pacemaker. Such 
irregularity of the rhythm is entirely due to a shift of the pacemaker from the 
sinoatrial node to the atrium and the atrioventricular (AV) junction, that is 
indicated by a gradual change of P wave axis and morphology. 
 
Atrial enlargement 
Abnormal P waves may be sign of atrial enlargement and/or hypertrophy. If this 
occurs in the right atrium, it typically produces increased P wave amplitude 
(greater than 2 mV in infants) with a normal P wave duration, usually more 
evident in lead II. Conversely, if this occurs in the left atrium, it typically 
produces an increased and prolonged negative terminal deflection of the P 
wave in lead V1 [19]. Abnormal P waves may also be seen in infants with non-
sinus origin of the P wave, with ectopic atrial rhythms whose origin is in other 
sites of the right or left atrium.  
 
Atrioventricular conduction abnormalities: Atrioventricular blocks 
If the PR interval is greater than the upper limit for corresponding age, 
atrioventricular conduction abnormalities are present. Atrioventricular (AV) block 
describes delayed or incomplete conduction of impulses through the AV node. 
Three degrees of AV block are recognized. First-degree AV block is defined as 
prolonged conduction through the AV node; this produces a prolonged PR 
interval on the ECG, but there is consistent 1:1 AV conduction. Second-degree 
AV block has two forms: Mobitz I and Mobitz II. Mobitz type I AV block (see 
appendix), also known as Wenckebach, is recognized on the ECG by its typical 
pattern of a gradually lengthening PR interval followed by a nonconducted P 
wave. In Mobitz type II AV block, there is intermittent failure of conduction of P 
wave, but wherever measurable PR intervals occur, they are consistent and do 
not lengthen. Generally, Mobitz II AV block produces a fixed ratio of P waves to 
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QRS complexes (2:1 or 3:1), but occasionally the AV block is variable [29]. First 
or second degree AV heart block can be observed in neonates and rarely it has 
been found progression to complete AV block after birth [30]. Functional AV 
block can be observed in neonates because they have a fast atrial rate and the 
P wave falls into the very prolonged T wave [19]. Long QT syndrome is 
occasionally complicated by impaired atrioventricular conduction, mostly 2:1 AV 
block [31,32]. Third-degree AV block (see appendix) is defined as complete 
failure of the conduction of atrial impulses to the ventricles. On the ECG, AV 
dissociation is seen when the atrial rate is faster than the ventricular rate [29]. 
AV block may be congenital or acquired. Congenital AV block is estimated to 
have an incidence of 1 to 22,000 births [33]. Congenital complete block can be 
observed in complex congenital heart malformations [34]. Mortality rate in 
patients with neonatal AV block is still high, especially during the first 3 months 
of life [35]. Acquired complete AV block is rare in neonates, and it is mainly due 
to viral myocarditis or may be related to tumours. In addition, it appears to be a 
strong association between SS-A/Ro or SS-B/La autoantibodies (present in 
collagen vascular diseases such as lupus erythematosis) of the mothers and 
the development of isolated neonatal AV block [36].  
 
Intraventricular conduction abnormalities: Bundle Branch Block 
Congenital isolated complete right and left bundle branch blocks are very rare in 
neonates. Only one case of complete RBBB in a population of 3383 apparently 
healthy newborn infants has been reported [37], RBBB with increased PR 
interval are seen in Ebstein’s anomaly of the tricuspid valve. Left anterior 
fascicular block is found in association with congenital heart malformations, 
such as atrio-ventricular canal defects and tricuspid atresia. Interruption of the 
left bundle, which results from the involvement of the left ventricle and/or its 
conduction system, has been reported in severe cardiomyopathy with poor 
prognosis [38]. Bundle branch block may also be inherited as an autosomal 
dominant trait [39,40]; when this happens, the subjects may show various 
combinations of conduction defects, from RBBB to AV block. 
 
Ventricular hypertrophy 
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Sensitivity and specificity of the ECG in recognition of ventricular hypertrophy 
has not been specifically tested in the neonate, besides recognition of left 
ventricular hypertrophy is poorer than generally recognized. Right ventricular 
hypertrophy may be suspected from a QR complex in V1, an upright T wave in 
V1 (normal in the first week of life), increased R wave amplitude in V1, and 
increased S wave amplitude in V6 (according to the Davignon criteria [20]). QR 
patterns are commonly seen with pressure overload congenital lesions, rSR’ 
patterns are seen in volume overload lesions. Left ventricular hypertrophy ECG 
signs in children have been described as T wave abnormalities in leads V5 and 
V6, increased R wave amplitude in V6, increased S wave amplitude in V1 
(according to the Davignon criteria [20]), and a combination of these last two 
variables. Left to right shunt lesions may manifest as biventricular hypertrophy. 
Left ventricular hypertrophy in the newborn may be attenuated by the normal 
right-sided predominance of the newborn. 
 
Premature beats  
Other pacemakers than the S-A node, that are generally activated only if an 
impulse from above fails to arrive, may assume an active role and discharge an 
electrical impulse out of turn, before the expected stimulation from above 
arrives. Such premature single impulses are called ectopic beats or premature 
beats. They may originate at any point of the conducting system or even in 
abnormally stimulated heart muscle cells. Atrial or junctional (A-V nodal) 
impulses are called supraventricular beats. Ectopic impulses originating in the 
lower portion of the conducting system are called ventricular beats [15]. A 
premature atrial beat is a premature P wave, that usually have a different 
morphology and mean vector from sinus P waves and that may be conducted to 
the ventricles normally, or with ventricular aberration or not conducted or 
‘blocked’. The latter some times occur in a bigeminal sequence, so-called 
‘blocked atrial bigeminy’. Premature atrial beats conducted normally, aberrantly 
and blocked may occur together. In infants, premature atrial beats may be 
conducted with either RBBB or left bundle branch aberration. If the QRS 
complex has a different morphology from the sinus, and is not preceded by a 
premature P wave, is a premature ventricular beat. Both premature atrial beats 
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and premature ventricular beats, which are manifest as premature P wave 
preceding a wide QRS, rarely occur in infants [19]. 
 
Supraventricular tachycardia 
Supraventricular tachycardia (SVT) refers to a sustained tachyarrhythmia that 
originates above the bundle of His. SVT is the most common abnormal 
tachyarrhythmia in children, with an estimated incidence in the pediatric 
population of 0.1% to 0.4% [41] In infants the rhythm typically appears with an 
extremely regular R-R interval after the first 10–20 beats. Rates vary from 260 
to 300 bpm depending on the patient’s age and the SVT mechanism. On the 
ECG, in 60% of cases, P waves are visible and have always a different 
morphology from sinus. In over 90% of infants and children with SVT, the QRS 
complex is usually normal in configuration, but in less than 10% of cases the 
QRS is wide due to aberrant conduction to the ventricles [41]. Several SVT 
mechanisms have been identified. The vast majority of SVT rhythms are either 
due to a re-entrant circuit, with or without an accessory pathway, or to an 
automatic ectopic focus. Triggered activity accounts for a very small percentage 
of SVT. The relative incidence of different types of SVT varies with age. Atrio-
Ventricular Reciprocating Tachycardia (AVRT) has a relatively high incidence 
among newborns and infants, with male patients affected more than female 
patients. AVRT is a common type of SVT that relies on at least two electrical 
connections between the atria and ventricles: the AV node and an accessory 
pathway (more than one accessory pathway may be present). Conduction 
proceeds antegrade down one pathway and retrograde up the other to form a 
re-entrant circuit. Nearly 75% of the SVT rhythms in children are mediated by 
accessory pathways. The most common form of AVRT is orthodromic 
reciprocating tachycardia, which involves antegrade conduction down the AV 
node to the ventricles and retrograde conduction up the accessory pathway to 
the atria. Antidromic reciprocating tachycardia (down the accessory pathway, up 
the AV node) occurs in less than 10% of patients [29]. In many of these infants 
SVT will spontaneously resolve by 6 to 12 months of age, but over 30% will 
have recurrence later in life [42]. Among patients with AVRT, about half of them 
have a concealed accessory pathway, meaning that pre-excitation is not evident 
on the 12-lead ECG [43]. AV nodal re-entrant tachycardia is virtually unseen in 
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neonates, but occurs more frequently with increasing age, and represents over 
50% of the SVT in adults. Other types of supraventricular arrhythmias, such as 
atrial fibrillation or multifocal tachycardia, are extremely rare in the neonate [19]. 
 
Atrial flutter 
Intra-atrial re-entrant tachycardia (IART), commonly referred to as atrial flutter, 
is a reentrant tachycardia that is confined to the atria (fig. 3). Propagation of 
IART relies on an electrical pathway within the atria with both an area of slow 
conduction and an anatomic obstruction that results in unidirectional block. This 
milieu for IART exists after atrial surgery for congenital heart disease and in 
fact, almost 95% of atrial flutter diagnosed beyond infancy is associated with 
structural heart disease [43]. On infant ECG (see appendix), a regular 
appearance of atrial depolarization, characteristic saw-tooth waves (flutter 
waves) are seen at rates of 300 to 500 bpm with variable AV conduction. 
Occasionally atrial flutter is associated with WPW syndrome [19]. 
 
Atrial fibrillation  
Atrial fibrillation (AF) demonstrates a rapid atrial rate with a very chaotic pattern, 
and an irregular ventricular rhythm, caused by chaotic electrical impulses in the 
atria with loss off coordination between the atria and ventricles. A typical ECG in 
atrial fibrillation shows a rapid irregular tachycardia in which recognizable P 
waves are absent. QRS complex are generally normal. The chaotic electrical 
activity produces deflections on the ECG, referred as fibrillatory waves. They 
vary in size and shape and are irregular in rhythm. AF is extremely rare in 
childhood and extremely uncommon before adolescence, but has been 
occasionally reported in all pediatric age groups and in fetuses [44,45]. It has 
been described in adult patients as a possible manifestation of sinoatrial 
disease, but this disorder accounts only for a minor portion of atrial fibrillation in 
childhood. AF has usually been associated with structural heart disease such as 
rheumatic heart disease, congenital heart disease, and various form of 
cardiomyopathy [46]. There are a few patients with atrial fibrillation without 
evidence of an underlying structural cardiac defect, or a disorder of the cardiac 
conduction system. This so called idiopathic or lone atrial fibrillation reported 
mainly in adults, has been documented also in very few children [44]. 
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Ventricular tachycardia 
Ventricular tachycardia (VT) is defined as three or more consecutive premature 
ventricular complexes at a rate greater than 120 bpm but usually less than 250 
bpm [29]. The QRS complexes are typically with a prolonged duration for the 
age group with AV dissociation (sinus P waves continuing unrelated to VT). 
There may be also retrograde P waves or no visible P waves. VT in infants is 
called a “wide QRS” if complex duration is greater than 90 ms [19]. Abnormal 
QRS complex originate from ventricles, but the specific morphology of the QRS 
is generally not helpful to distinguish VT from SVT with aberration. In infants, 
the rate of VT may be from 200–500 bpm and it is possible a slight variation in 
the R-R interval over several beats. VT that occurs at a rate less than 200 bpm 
and alternating to sinus rate is called “slow VT” or Accelerated Ventricular 
Rhythm [19]. VT may be unsustained (lasting less than 10 seconds) or 
sustained (lasting 10 seconds or longer). Monomorphic VT refers to tachycardia 
in which all the QRS complexes have a similar morphology, in contrast to 
polymorphic VT with multiform complexes. Torsades de pointes (“twisting of the 
points”) is a type of polymorphic VT characterized by rapid, wide, undulating 
QRS complexes that appear to be spiraling around an axis. Mechanisms for VT 
are not as well described as for SVT, but appear to include re-entry (similar to 
IART), abnormal automaticity, and triggered activity [29]. The incidence of VT in 
the pediatric population is unknown, but accounts for about 6% of patients 
followed for tachyarrhythmia [47]. VT may be associated with severe electrolyte 
or metabolic abnormalities, hypoxia, hypothermia, or drug toxicity. Cardiac 
conditions such as cardiomyopathy, myocarditis, arrhythmogenic right 
ventricular dysplasia, ventricular tumors, surgery for congenital heart disease 
may create a substrate for VT. Another recognized cause of VT is congenital or 
acquired long QT syndrome [29]. 
 
Ventricular fibrillation 
Ventricular fibrillation (VF) displays unidentifiable QRS complexes due to an 
uncoordinated state of ventricular depolarization, resulting in a state of poor 
cardiac output. Significant ventricular dysrhythmias, such as VF, in the pediatric 
age range are most commonly encountered in the setting of congenital heart 
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diseases, myocarditis, cardiomyopthies, hypoxia, acidosis and electrolyte 
abnormalities [23]. 
 
Brugada syndrome  
The Brugada syndrome is a disorder associated with increased susceptibility to 
ventricular fibrillation and sudden cardiac death in the absence of cardiac 
structural abnormalities [48] and it is believed to be responsible for 4% to 12% 
of all sudden deaths [49]. Brugada syndrome may cause sudden death in 
children even in the first months of life when it may be misdiagnosed as SIDS. 
Priori and colleagues [12], in a single family study, demonstrated that an 
unusual form of Brugada syndrome with extremely severe manifestation in early 
childhood caused familial sudden death after unexplained cardiac arrest in five 
children from the same family. Brugada syndrome, that was suspected based 
on the transient manifestation of the typical electrocardiogram pattern in one of 
these children, was confirmed by genetic analysis. Incomplete penetrance, 
where a parent with a normal ECG may still carry and transmit the mutation, 
has been reported in Brugada syndrome [50] and has been seen in this family, 
where three gene carriers were completely asymptomatic with normal ECG. 
Suzuki et al. [13] reported the youngest patient documented to have Brugada 
syndrome, a 6-month-old Japanese infant with a malignant form of Brugada 
syndrome, who had frequent episodes of ventricular fibrillation (VF) and 
unsustained polymorphic ventricular tachycardia (VT). Moreover, his twin died 
suddenly during sleep at the age of 4 months. The most typical 
electrocardiographic features of the Brugada syndrome include an accentuated 
J wave appearing principally in the right precordial leads (V1 to V3) and taking 
the form of an ST-segment elevation, often followed by a negative T wave. In 
most patients, however, the typical widened S wave in the left lateral leads is 
absent, suggesting that this is not true RBBB. Early high takeoff of the ST 
segment in the right precordial leads (the “J wave”) can mimic RBBB [51]. Two 
ST-segment morphologies have been described in leads V1, V2, and V3: 
convex curved or “coved” and “saddle shaped”–type ST-segment elevation [52-
54]. In individual patients, both morphologies may subsequently be present. The 
presence of coved ST-segment elevation has been suggested to have a 
stronger arrhythmogenic potential [52,54] but this relation could not be 
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confirmed by others [53]. ECG abnormalities are inconsistently present 
[9;48,55-57]. The intermittent nature of this electrocardiogram pattern may 
obscure correct clinical diagnosis and therefore genetic screening contributes to 
the diagnosis of the disease [9,58]. Like the long-QT syndrome, the Brugada 
syndrome has both congenital and acquired forms; the latter is just beginning to 
be recognized [49]. The hereditary nature of the syndrome, characterized by an 
autosomal dominant mode of transmission, is well established. Chen et al. [9] 
were the first in 1998 to link the syndrome to the alfa subunit of the cardiac 
sodium channel gene, SCN5A. Several dozen SCN5A mutations have been 
linked to the syndrome [59-61] but unlike those causing the LQT3 (where there 
is an abnormality in Na-channel inactivation, resulting in a gain of function 
mutation and a prolonged QT interval), SCN5A mutations leading to Brugada 
syndrome are invariably associated with a loss-of-function. Loss-of-function 
SCN5A mutations also lead to conduction defects, which are often part of the 
clinical picture in Brugada syndrome [9,62,63]. For example the syndrome may 
be unmasked during a febrile state [64] because of the premature inactivation of 
the mutant channel which is exaggerated at temperatures above the 
physiological range, and those patients with the Brugada syndrome may be at 
an increased risk. Another locus on chromosome 3, close, but distinct from 
SCN5A, was recently linked to the syndrome [65]. Only 20% of Brugada 
syndrome cases have been linked to SCN5A mutations. A long list of candidate 
genes encoding for a variety of ion channels and other proteins have been 
proposed [60,63]. Heterogeneity of repolarization across the wall of the RV 
outflow tract (RVOT) contribute to the ECG patterns and the genesis of 
extrasystoles and ventricular tachycardia in the Brugada syndrome. Action 
potentials (APs) of epicardial cells display a pronounced phase 1 (fig. 4A), 
referred to as spike-and-dome morphology or notch [66], which is the result of 
at least 3 different currents: INa, Ito, and L-type calcium current. Perturbations 
in these currents can lead to striking abbreviation of the epicardial AP, with the 
resultant potential for reexcitation based on epicardial-endocardial 
heterogeneity of repolarization. It has been hypothesized that, because of the 
thinness of the RV wall, the relative contribution of epicardial APs to the surface 
ECG is more prominent in right than left precordial leads. Hence, the impact of 
changes in epicardial AP morphology will be most pronounced in precordial 
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leads V1 and V2 facing the RVOT [62]. Under normal conditions, the ST 
segment is isoelectric because of the absence of transmural voltage gradients 
at the level of the action potential plateau. A reduction in the density of the 
sodium channel current, as occurs with the inherited mutations discussed 
above, is known to accentuate the epicardial action potential notch that leads to 
exaggeration of transmural voltage gradients and thus to accentuation of the J 
wave, causing an apparent ST-segment elevation as a result of transmural 
current flow from endocardium to epicardium [60,67]. If the epicardial 
repolarization precedes repolarization of the M-cells and endocardial regions, 
the T wave will remain positive and the result will be a saddleback form of ST 
segment elevation (fig. 4B). Further accentuation of the notch as a 
consequence of additional reduction of INa may be accompanied by a 
prolongation of the epicardial action potential such that the direction of the 
transmural voltage gradient is reversed, thus leading to the development of a 
coved-type of ST segment elevation and inversion of the T wave (fig. 4C), 
typically observed in the electrocardiograms (ECG) of patients with Brugada 
syndrome. The arrhythmogenic substrate is believed to arise when a further 
shift in the balance of currents leads to loss of the action potential dome at 
some epicardial sites, but not at endocardium, that results in the development of 
a marked transmural dispersion of repolarization and refractoriness, which is 
responsible for the development of a vulnerable window during which a 
premature impulse or extrasystole can induce a reentrant arrhythmia. Moreover, 
loss of the epicardial action potential dome at some sites but not others creates 
a dispersion of repolarization within epicardium (fig. 4D) [68]. Propagation of the 
action potential dome from sites at which it is maintained to sites at which it is 
lost causes local re-excitation by means of a phase 2–reentry mechanism, 
leading to the development of a very closely coupled extrasystole, which 
captures the vulnerable window across the wall, thus triggering a circus 
movement reentry (fig. 4E) in the form of VT/VF [66,68]. Despite substantial 
progress in the identification and characterization of the Brugada syndrome 
over the past decade, relatively little progress has been made in the approach 
to therapy. Pharmacological treatment does not protect effectively against 
recurrent events, and currently, implantation of an a cardioverter-defibrillator 
(ICD) is the only effective therapy to prevent sudden death [48,69-71]. This, 
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however, is not an adequate solution for infants and young children. The 
pharmacological approach to therapy is focused on a rebalancing of currents 
active in the early phases of the RV epicardial action potential so as to reduce 
the magnitude of the action potential notch and/or restore the action potential 
dome [49].  
 
Long QT syndrome 
The LQTSs are phenotypycally and genotypically diverse [72] but have in 
common the appearance of long QT interval on the electrocardiogram (ECG) 
[73-75], an polymorphic VT, and in many but not all cases, a relatively high risk 
for sudden cardiac death [72]. Other ECG abnormalities in LQTSs include 
prominent U waves, a T-U complex with an indistinct termination of the T wave, 
and broad T waves, which may be notched, biphasic, or inverted. T-wave 
alternans, an alternating amplitude and polarity of the T waves, also may be 
present [76]. All these changes in the electrocardiogram reflect differences in 
repolarizing currents across the ventricular wall (fig. 5). In LQT conditions, a 
disproportionate prolongation of action potential duration of the Purkinje fiber 
and the cells of the deep subendocardium/midmyocardium (the M cell) has 
been thought to be responsible for the development of LQT intervals, the 
different T-wave morphologies, and the U waves. The resulting dispersion of 
repolarization have also been shown to contribute to the malignant ventricular 
dysrhythmias [77]. Although other dysrhythmias can occur, the hallmark 
dysrhythmia is torsades de pointes (“twisting of the points”) (see appendix) [78, 
79]. In 1975 [73] two hereditary variants were included under the unifying name 
of ‘Long QT Syndrome’: a more common autosomal dominant form with a pure 
cardiac phenotype [80,81] and a rare autosomal recessive form characterized 
by the coexistence of cardiac abnormalities and congenital deafness [82]. They 
are referred to as the Romano–Ward syndrome and the Jervell and Lange–
Nielsen syndrome (J-LN) respectively. Since 1995, when the first two genes 
responsible for LQTS were identified [83,84], molecular genetic studies have 
revealed a total of eight forms of congenital LQTS caused by mutations in 
genes of the potassium, sodium and calcium channels or membrane adapter 
located on chromosomes 3, 4, 7, 11, 12, 17 and 21 [85-88] (see appendix). 
Mutations in KCNQ1 and KCNE1, the α and β subunits of the potassium 
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channel gene, respectively, are responsible for defects (loss of function) in the 
slowly activating component of the delayed rectifier potassium current (IKs) 
underlying the LQT1 and LQT5 forms of LQTS [89,90]. Mutations in KCNH2 
and KCNE2 cause defects in the rapidly activating component of the delayed 
rectifier potassium current (IKr) responsible for the LQT2 and LQT6 forms 
[83,91]. Mutations in SCN5A, the gene that encodes the a subunit of the sodium 
channel, result in an increase (gain of function) in the late sodium current (INa) 
responsible for LQT3 [84]. Most recently, a mutation in CACNA1C was reported 
to be responsible for the defect in the L-type calcium current (ICa-L) underlying 
the LQT8 form, an arrhythmia disorder associated with dysfunction in multiple 
organ systems, including congenital heart disease, syndactyly, immune 
deficiency, and autism [85]. Mutations in KCNQ1 [92] and KCNE1 [89,90] are 
responsible also for the J-LN syndrome [93] and are present as homozygous or 
compound heterozygous defects [94]. It is thought by several authors [58,95] 
that the so-called LQT4 [87] and LQT7 [96] associated with a mutation in 
Ankyrin-B, a membrane adapter, that leads to the intracellular Ca2+ overload 
[87] and mutations in KCNJ2 encoding for the inward rectifier potassium current 
(IK1) [86] respectively, represent disorders different from the classic LQTS; 
because the fact that they can be associated with some degree of QT 
prolongation, usually rather modest, does not justify to consider them part of 
LQTS, a disease with very specific clinical manifestations. Approximately 10% 
of children with LQTS will present with sudden death, and younger children are 
more likely to die suddenly [78,79,97]. Ventricular tachyarrhythmias stemming 
from congenital long QT syndrome (LQTS) specifically have been postulated to 
account for some cases of sudden infant death syndrome (SIDS) [11,98-100]. 
The suggestion that the same mechanisms operant in LQTS could contribute to 
some of the SIDS victims was advanced in 1974 to 1976 [101,102] but the first 
evidence, that a prolonged QT interval was associated with a significantly 
higher risk of SIDS was provided in 1998 from the large cohort study by 
Schwartz et al. [11]. They documented strong clinical evidence of an 
association between prolongation of the QT interval and SIDS [103] in a 19-year 
prospective collection of day 3 or 4 of life screening 12-lead ECG on 34,442 
neonates. From this original cohort, 34 infants died within their first year with 24 
secondary to SIDS. The average QTc among the 24 SIDS was 435±45 ms. 
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Further, 12/24 of the SIDS decedents had manifest a QTc exceeding 440 ms 
[11] This study demonstrated QTc as a significant risk factor for SIDS in day 
3/day 4 of life, QTc>440 ms having a 41.3 odds ratio for SIDS, an odds ratio far 
greater than other established risk factors for SIDS such as prone sleep position 
and environmental exposure to smoke. This study was followed by molecular 
demonstrations that “de novo” LQTS mutations created an arrhythmia-prone 
substrate responsible for cardiac arrest, as a result of documented ventricular 
fibrillation, in a typical case of near-miss for SIDS and another one caused by 
SIDS [99,104]. These findings provided the necessary “proof of concept” that 
LQTS could cause SIDS but their limit was represented by their anecdotal 
nature. A postmortem molecular screening of a cohort of 93 SIDS victims 
showed a prevalence of LQTS mutations of 5.2% among the 58 white infants 
[100]. The prevalence of LQTS gene variants in sudden infant death are also 
assessed recently through a molecular study in a cohort of 201 Norwegian 
SIDS victims. Arnestad et al. [105] identified 8 mutations and 7 rare variants in 
9.5% of SIDS victims which were not seen in controls. This last study 
strengthens the molecular evidence that some SIDS cases result from cardiac 
electrical diseases, such as congenital LQTS [106]. These findings have direct 
clinical implications and the treatment of all those diagnosed as affected is even 
if there are no symptoms [19]. Therapy is aimed at reducing sympathetic activity 
to the heart, either pharmacologically or surgically. Beta-blockers are generally 
recommended as the initial therapy of choice, as they have been shown to 
significantly reduce episodes of syncope and sudden death with a decrease in 
mortality from 71% in untreated patients to 6% in those treated with beta-
blockade [107]. All beta-blockers seem to be effective, but propanolol and 
nadolol are most commonly used [108] Furthermore, beta-blockers have been 
shown to effectively eradicate dysrhythmias in 60% of patients [97]. Although 
many patients with congenital LQTS have a resting bradycardia, most tolerate 
high dose beta-blockade [76]. Some patients may require a pacemaker 
because of drug-induced bradycardia superimposed on their already slow 
heartbeat [79]. Approximately 20% of patients remain refractory to treatment 
with betablockers and continue to experience recurrent syncope [107]. A direct 
link between mutations in the ion channel genes and each genotype has made 
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possible the advent of genotype-specific treatments for each LQTS genotype as 
reported first by Schwartz et al. in 1995 [109]. 
 
Wolff-Parkinson-White syndrome 
The Wolff-Parkinson-White (WPW) syndrome is a frequently encountered type 
of AVRT. Orthodromic reciprocating tachycardia (fig. 6) results from reentry 
antegradely through the atrioventricular node and retrogradely through the 
accessory pathway (a direct muscular connection between the atria and 
ventricles). Conduction through the atrioventricular node and the accessory 
pathway (Kent bundle) results in collision of two electrical wavefronts at the 
ventricular level that appears as a delta wave and a fusion QRS complex with 
prolonged duration, along with a shortened PR interval. The diagnosis of 
ventricular preexcitation is solely based on the findings of the surface ECG (see 
appendix). In newborns and infants intermittent preexcitaton are common [19]. 
A study in newborns reported a high prevalence of WPW syndrome when 2 of 4 
following characteristics were noted: PR interval ≤ 100 ms, QRS complex 
duration ≥ 80 ms, lack of a Q wave in V6 and left axis deviation [110]. WPW 
syndrome prevalence in the pediatric population has been estimated at 0.15 to 
0.3% [111] which arrives to 0.5% in children with structural heart disease [42]. 
There is an increased incidence of WPW in patients with Ebstein’s anomaly, 
tricuspid atresia and hypertrophy cardiomyopathy [112]. Tachycardias 
associated with the syndrome are usually paroxysmal and may produce 
symptoms of presyncope, syncope, and cause sudden death [113]. Presence of 
the accessory pathway predispose to the atrial fibrillation (AF) (observed in 40% 
of cases with the WPW syndrome) with very fast ventricular response (fast 
conducting via the accessory pathway). Extremely fast ventricular rate may 
induce ventricular fibrillation. The risk of sudden cardiac death is 0.15% per 
year [114], however during the whole life it is greater than 10%. The incidence 
of sudden death in preexcitation syndrome during childhood has been 
estimated to be as high as 0.5% [115] and cardiac arrest may be the initial 
presentation in children with preexcitation [116]. However, data on newborns 
and infants are lacking. One study on a series of 90 newborns and infants with 
WPW syndrome and supraventricular tachycardia reported sudden death in two 
patients with a normal heart during follow-up. Both infants, however, had been 
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treated with digoxin [117]. As digoxin shortens the antegrade effective refractory 
period of the accessory pathway and promotes rapid atrioventricular conduction 
during atrial flutter or atrial fibrillation over the pathway, the use of digoxin is 
contraindicated at any age [118,119]. Verapamil should also be avoided as it 
may increase the ventricular response rate during atrial fibrillation in those 
patients, and may cause cardiovascular collapse in infants and young children 
[19]. A recent study by Gollob et al. [113] examined members of 2 families in 
whom the condition occurred as a familial autosomal-dominant disorder with 
complete penetrance and variable degrees of expression. They identified a 
mutation in the gene that encodes the gamma-2 regulatory subunit of the AMP-
activated protein kinase. The molecular defect found may, in some way, inhibit 
the normal regression of muscle fibers during atrioventricular septation. 
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Methods 
Study Population 
From October 2001 to February 2006, all mothers of newborns discharged from 
the nursery of the “Perrino” Hospital in Brindisi, were invited to bring back their 
babies for the electrocardiographic screening, between the fifteenth and twenty-
fifth day of life of the infant, as recommended by the Guidelines of the European 
Society of Cardiology [19]. At discharge, mothers were given an informative 
leaflet with recommendations on behaviors to adopt in order to reduce the risk 
of SIDS (see appendix), thus also improving the medical education in the 
overall population. 
Electrocardiograms were recorded in a total of 2619 neonates. They were all 
healthy and full-term babies, as the very premature and sick newborns, who 
had been transferred to intensive care units, were excluded from the study.  
 
Data acquisition 
Demographic and clinical data 
The demographic data of newborns and of their parents were collected, as well 
as the clinical history of the newborn babies and of their mothers.  
 
Electrocardiography 
ECGs were carried out by pediatric nurses trained to make ECG on newborns. 
Twelve-lead electrocardiograms were recorded at paper speed of 25 mm per 
second with Cardioline Delta 60 Plus recorder. The amplitude and duration of 
the waves and the intervals length in the newborn babies’ ECGs were hand 
measured, as the computerized systems are often inadequate in the newborns 
[19]. The electrocardiograms were analyzed by a neonatologist, expert in 
pediatric cardiology, who for the interpretation of the neonatal electrocardiogram 
referred to the guidelines [19], created by the Task Force of the European 
Society of Cardiology (ESC). 
All electrocardiographic parameters were measured according to the guidelines 
for the interpretation of neonatal ECG [19]. In particular, RR and QT intervals 
 28
were measured in lead II in five nonconsecutive beats, using the longest value. 
The corrected QT interval (QTc) was calculated by dividing the QT interval by 
the square root of the RR interval (Bazett’s formula) [24]. 
 
Database  
Every participating center has been provided with a username and password to 
access the online database (www.hyperphar.com) created for the multi-center 
project. Demographic, clinical and electrocardiographic data of all newborns 
enlisted in the study were entered into the neonatal ECG database. ECG 
tracings were transmitted from the participating center to the coordinating center 
in order to build a database of neonatal ECG traces. 
 
Clinical management and follow-up 
Newborns with clinically relevant ECG abnormalities were followed-up, 
according to the guidelines work-up section for clinical management of 
pathologies related to ECG anomalies [19] with the support of the Istituto 
Auxologico Italiano. The clinical outcome at 12 months was obtained via 
telephone interview to the parents and the referring physician. 
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Statistical analysis 
Statistical analysis was performed using the SAS statistical software (SAS 
Institute Inc, Cary, NC) versions 8.2 for Microsoft Windows. Continuous 
variables were presented as the mean ± SD and as minimum and maximum 
value. Data were processed using SAS procedures as PROC FREQ for 
frequency tables; PROC MEANS and PROC UNIVARIATE for percentile 
distribution graphs of data. 
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Results 
Results of ECG screening 
During the study period 2619 infants have been enrolled. The age range of the 
infants was from 7 to 94 days (mean age 31days). 1317 (50.3%) babies were 
male and 1302 (49.7%) were female. To define abnormalities findings on the 
electrocardiographic trace we referred to tables of normal electrocardiographic 
values in the paediatric population published in 1979 by Davignon et al. [20], 
and also to values and criteria indicated in the guidelines for the interpretation of 
neonatal ECG [19]. 
Of the 2619 ECGs 1610 (61.5%) were of infants in the first month of life (821 
male and 789 female), and 1009 (38.5%) were of infants from one to three 
months (496 male and 513 female). The percentile distribution of 
electrocardiographic variables of the 2619 ECGs was obtained with the SAS 
statistical software and the results are shown in the tables.  
The mean heart rate was 157±15 bpm in the whole population. Sinus 
tachycardia was discovered in 207 babies (7.9%) whilst sinus bradycardia in 27 
babies (1%). No newborns presented sinus pauses. Findings of 
supraventricular ectopic beats were detected in 3 cases (0.1%), whilst only one 
case showed ventricular ectopic beats.  
The mean PR interval was 100±10 ms; short PR intervals occurred in 25 cases 
(PR≤ 70 ms) and only in one were they associated with delta waves (Wolff-
Parkinson-White syndrome). No atrial enlargement was found, as no infant 
presented abnormal P wave amplitude(1.2±0.4 mV) or duration (41±6 ms), 
however, there were 3 (0.1%) cases of ectopic atrial rhythm as in those infants 
the P wave showed a non-sinus origin (P wave axis from 0 to –90°). 
The mean duration of the QRS complex was 64±6 ms; normal values were 
found in all ECGs, although 60 (2.3%) of them presented typical signs of 
incomplete RBBB. The mean QRS axis was 98°±39°. There were 8 (3%) cases 
of Left Axial Deviation (LAD) (from 0°to –90°) and 8 (3%) cases of extreme 
Right Axial Deviation (RAD) (from -180° to -90°). 
The mean QT and RR intervals were 248±17 ms and 386±40 ms respectively. 
The mean QTc in the whole population was 400±21 ms, (399±20 and 402±21 
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ms, for boys and girls respectively). As reported by guidelines [19] we 
considered a prolonged QTc greater than 440 ms. With regard to this subject 
we found 69 (2.6%) infants with QTc greater than 440 ms. Among these, 66 had 
QTc between 440 ms and 470 ms (males and females under 1 month 447±8 
and 451±8, respectively; males and females over 1 month 446±5 and 447±7, 
respectively); 3 (0.1%) had QTc greater than 470 ms (one male 482; two 
females 478 and 486 respectively). 
ST segment elevations were present in 5 (0.2%) infants and in one of these 
cases, there was an elevation in the right chest leads. Electrocardiographic 
signs of ventricular hypertrophy were found in 2 (0.07%)infants.  
 
Follow-up results 
Of the 2619 infants enrolled, follow-up data were available for 1656 (63.2%). 
The remaining 963 were lost to follow-up for reasons that do not relate to the 
study. 
According to each single case, on the basis of ECG abnormalities, the 
evaluation of these infants was performed as reported by the guidelines [19]. 
The infant with preexcitation pattern on surface ECG, as in the Wolff-Parkinson-
White syndrome, was evaluated with a complete 2-dimensional 
echocardiographic work-up to rule out any intracardiac abnormality. The first of 
the three infants with ectopic atrial rhythms was lost to follow-up. The other two 
babies were screened with a second ECG. One of them had sinus rhythm which 
was diagnosed with the second ECG; the other one had a rare congenital heart 
malformation that was revealed only when the echocardiogram was performed 
(absent right superior vena cava in situs solitus with persistent left superior vena 
cava with drainage to coronary sinus). 
In the cases with extreme Right Axial Deviation (RAD) an echocardiogram was 
performed and all results were negative for heart diseases. 
A second ECG was performed in 58 infants with QTc greater than 440 ms and 
in these cases a subsequent work-up had to be followed according to the flow 
chart for QT prolongation management (see appendix). The other 11 infants 
with QTc>440 ms were lost to follow-up, among these also one of those cases 
with QTc>470ms.  
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In one case an infant at the first ECG had the QTc between 440 ms and 470 
ms, however, at the second ECG the QTc was normal, but the infant showed 
signs of ventricular hypertrophy. Thus, the infant underwent further screening. 
The echocardiogram revealed an aortic coartaction with severe cardiac failure, 
a congenital cardiovascular defect. Subsequently, the baby received surgical 
correction in the first month of life. 
A second ECG was performed in the two infants with a QTc greater than 
470ms; in one case the QTc value was between 440ms and 470 ms, in the 
other case the QTc was >470 ms. The infants were referred to the coordinating 
center (Istituto Auxologico Italiano) for molecular screening. Infants with signs of 
ventricular hypertrophy were lost to follow-up. 
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Discussion 
The data reported in this paper have been collected at the “Perrino” Hospital, 
one of the 16 centers participating to the largest prospective study ever carried 
out on the assessment of prevalence of electrocardiographic abnormalities in a 
neonatal healthy population. The data collected only represent 5.9% of the 
entire study population (44.596 infants) [120]. Of the 2619 ECGs recorded over 
a period of almost 5 years, 418 (16%) presented abnormalities. Among the 
abnormalities 5 (0.2%) had a major clinical significance, such as prolonged QT 
syndrome, Wolff-Parkinson-White syndrome and congenital heart disease. 
In our population of newborns we found 69 cases (2.6%) of QT corrected that 
was greater than the established upper limit of normality for newborns [11]. The 
sensitivity and specificity of QT measurements on the infant ECG, obviously 
depend on the threshold cut-off designated as abnormal, and a single QTc 
measurement on a resting ECG does not identify all infants with congenital 
LQTS [121]. Moreover, taken together all QTc interval values exceeding 440 
ms, do not consent to distinguish between prolongations of the QT interval that 
are significant but not clinically important, and those that are clinically relevant. 
The QT interval is not a discrete variable (yes/no) but is a continuous 
quantitative measure therefore, with few exceptions, the risk of life-threatening 
arrhythmias is low for slight QT prolongation and increases with QT duration 
[122]. As to the guidelines [19], the action plan of the study advised as a first 
step to perform electrocardiographic recording at the age of 15–25 days, in 
order to significantly lower the number of false-positive results, thus limiting the 
subsequent electrocardiographic controls to a much smaller number of infants. 
Secondly to repeat the ECG after a few days, so as to confirm the abnormal 
findings recorded in the first ECG. Lastly to consider treatment for those 
neonates who have QTc (confirmed by second ECG measurement) greater 
than 470 ms, but only after having excluded other possible causes of acquired 
QT interval prolongation, and after having considered the family history, in case 
of familial LQTS. Neonates affected by long QT syndrome with a QTc greater 
than 470 ms are at high risk for sudden death both in infancy and later in life 
[123]. In our screened population two were the babies belonging to this group. 
This finding fits with current estimation of LQTS prevalence of 0,7/1000, on the 
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basis of preliminary data collected in 44.596 infants [120]. The early 
identification of these still-asymptomatic newborns affected by LQTS is one of 
the main objective of neonatal ECG screening program. The screening, 
originally proposed on the basis of the first solid evidence linking QT 
prolongation and risk of SIDS [11] has brought several benefits both to babies 
and their families, as already preannounced by its “supporters” [124]. As a 
matter of fact, following the identification of this abnormality through neonatal 
ECG, the ECG screening of family members has enabled to identify other 
relatives with QT prolongation. The difficulty in this situation might be the 
incomplete penetrance expressed by the disease [125]. Thus, genotyping of the 
probands, to find a disease-causing mutation and to confirm the early diagnosis 
ECG-based, has facilitated a rapid screening of all relatives enabling 
recognition of “silent” mutation carriers within the extended families: two of four 
screened in one family, ten of thirteen screened in the other family. Moreover, 
genetic analysis establishing LQTS subtype, had important implications. One 
family had a mutation in the KCNQ1 gene of chromosome 11 causing the LQT1 
syndrome [72], whilst the other family had a mutation in the KCNH2 gene of 
chromosome 7 causing the LQT2 syndrome [72]. The identification of the 
genotype enables a more tailored approach with regard to the management of 
LQTS subjects, as it allows to observe the relationship between the genotype 
and its specific triggers, and the response gene specific to different treatment 
[126]. Data from several LQTS families showed that β-blocker treatment has 
reduced mortality below 3% in symptomatic subjects, and below 1% in 
asymptomatic subjects [127,128]. The efficacy of β-blockers in greatly reducing 
life-threatening cardiac events in neonates with long QT syndrome has already 
been proven [107,127,129,130]. Arnestad et al. [105] have recently 
demonstrated that genetic arrhythmogenic disorders like LQTS, are responsible 
for nearly 10% of rigorously defined SIDS, thus reducing the number of sudden 
infant deaths which, because they occur in an apparently healthy infant and 
remain unexplained after careful examination [131], would be hidden under the 
umbrella of SIDS. Given the conclusive evidence that correlates SIDS to LQTS 
[105] it seems logical that this neonatal ECG screening, performed as 
suggested by the Task Force of the European Society of Cardiology [19] in the 
third and fourth weeks of life, when the prevalence of spurious marked QT 
 35
prolongations (QT>470 ms) is minimal [120], preventing LQTS-related deaths of 
which some occur in the first few months of life, can contribute to prevention of 
SIDS, but it can also prevent many LQTS-related deaths occurring in childhood 
and later in life, especially in subjects under the age of 30, which are reported 
as Sudden Unexpected Death (SUD) [132]. 
Furthermore, one case of coartaction of the aorta, a significant life-threatening 
congenital heart disease, was identified. Routine physical examinations are 
unable to detect over 50% of the critical congenital cardiovascular 
malformations (CCVMs) in infants [133]. The risk of discharging from nursery 
infants with undiagnosed CCVMs appears to be elevated, as 10% of these 
infants who die in the first year of life and 25% of those who die in the first week 
of life have not been diagnosed any disease before death [134-136]. Therefore, 
an ECG screening performed in the first month of life can contribute to detect 
cases of CCVMs that were not detected during the initial medical visits, but that  
require surgical correction or interventional procedures during the first month of 
life [137]. It has been documented that children with CCVMs are at 
approximately 12 times higher risk of mortality in the first year of life, than the 
general population [138]. Medical investigation prompted by ECG abnormalities 
in this asymptomatic infants, allowed early identification of CCVM and 
correction by angioplasty before irreversible damage or death. 
The finding of rhythm abnormalities, as ectopic atrial rhythm, on ECG trace has 
allowed detection of an infant with malformation which consisted in the absence 
of the right superior vena cava (SVC) in situs solitus, with persistent left superior 
vena cava with drainage to coronary sinus. This rare condition (0.07% to 0.13% 
of congenital cardiovascular malformations) [139] that in some cases also 
presents additional heart defects [139], is generally clinically silent. However, it 
is important to be aware of having this defect, thus to avoid various 
management difficulties during invasive medical or surgical procedures. 
The Wolff-Parkinson-White syndrome, whose prevalence in pediatric population 
has been estimated at 0.15 to 0.3% [111], in our population of newborns was 
detected in only one case. Diagnostic assessment and treatment have been 
described in details in the symptomatic WPW syndrome, but little information 
exists about significance and prognosis of an incidentally found ventricular pre-
excitation in asymptomatic children [140]. In most cases they are assumed to 
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have a benign prognosis, although they do very occasionally present with 
ventricular fibrillation as the first manifestation of the syndrome [141]. 
Discovering a WPW pattern on ECG of an asymptomatic newborn identifies the 
necessity for more accurate screening tests in order to assess the risk of life-
threatening arrhythmias. However, non-invasive methods seem to be relatively 
incomplete for risk stratification, and current guidelines do not always 
recommend a routine electrophysiological study in patients with an 
asymptomatic WPW ECG pattern, especially in children younger than 12 years 
[141]. Hence, the management of asymptomatic WPW subjects remains 
controversial. 
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Conclusions 
Although life-threatening arrhythmias are rare in infants, they are very serious 
and must be sought to avoid both short- and long-term morbidity and mortality. 
The electrocardiographic screening for neonates, as an additional measure of 
prevention, especially for the early identification of infants at risk of life-
threatening arrhythmias, is available and relatively at low cost [142], and can 
also help detecting complex cardiac malformations. With regard to the 
effectiveness of this preventive approach in reducing morbidity and mortality in 
infancy and childhood, it will be necessary to carry out a thorough analysis of 
the data collected by the network of neonatology and cardiology units.  
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Mean, Standard Deviation, Minimum, Maximum QTc value according to sex and age group 
 
Male Female 
N.  
ECGs Mean SD Min  Max 
N.  
ECGs Mean  SD Min Max 
QTc 
Until 1 month Until 1 month 
           
<=440 806 395,7 18,6 346,0 438,0 775 398,4 18,8 446,0 437,3 
440<=QTC<470 14 447,5 8,1 442,7 466,7 13 450,9 8,4 443,0 466,7 
>=470 1 482,4 - 482,4 482,4 1 478,3 - 478,3 478,3 
 Over 1 month Over 1 month 
<=440 480 401,1 19,6 347,0 439,0 489 402,9 20,1 354,0 439,0 
440<=QTC<470 16 445,8 4,7 442,7 458,5 23 447,3 6,6 442,7 462,9 
>=470 - - - - - 1 486,7 - 486,7 486,7 
 
 
 
 
 
 
 
 
Electrocardiographic values according to age group 
Age group 
 
Heart rate1 
(bpm) 
 
QRS axis2 
(degrees) 
 
 
P wave 
amplitude3 
(mm) 
 
PR interval4 
(ms) 
 
QV6
5 
(mm) 
 
R V1
6 
(mm) 
 
S V1
7 
(mm) 
R/SV1
8 
 
R V6
9 
(mm) 
 
S V6
9 
(mm) 
R/SV6
10
 
SV1+RV6
11
(mm) 
 
R+S 
V4
12 
(mm) 
Until 
1 month 
98-218 
(157) 107 1.3 80-120 (99)
0-3 
(0.9) 
3-15 
(7.2) 
0-12 
(2.9) 
0.4-10 
(2.7) 
2-17 
(6.4) 
1-11 
(3.3) 
0.4-10 
(2.7) 
0-10 
(2.8) 
8-28 
(15) 
Over 
1 month 
108-220 
(158) 83 1.2 
80-120 
(101) 
0-3 
(1.2) 
3-16 
(6.9) 
0-13 
(3.2) 
0.5-15 
(3.6) 
3.5-21 
(8.4) 
1-10 
(2.3) 
0.5-15 
(3.6) 
0-10 
(2.5) 
10-33 
(18) 
1 min-max (mean) 
2 mean (511 missing) 
3 mean (963 missing) 
45th-99th percentile (mean) (2 missing) 
55th-99th percentile (mean) (1254 missing) 
65th-99th percentile (mean) (1201 missing) 
75th-99th percentile (mean) (1206 missing) 
85th-99th percentile (mean) (1481 missing) 
95th-99th percentile (mean) (1208 missing) 
105th-99th percentile (mean) (1481 missing) 
115th-99th percentile (mean) (1480 missing) 
125th-99th percentile (mean) (1482 missing) 
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fig. 1: ECG and electrical views of the heart from various angles. 
 56
 
 
fig. 2: The conduction system and the depolarization sequence of the normal 
ECG.  
From ref. [143] 
 57
 
 
fig. 3: Mechanism of Atrial Flutter(Intra-Atrial Re-entrant Tachycardia) 
From ref. [29] 
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fig. 4: Schematic showing right ventricular epicardial action potential changes 
thought to underlie the ECG features of the Brugada syndrome. 
From ref. [144] 
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fig. 5: Different repolarizing currents across ventricular wall in LQTSs 
From ref. [77] 
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fig. 6: Mechanism of Wolff-Parkinson-White Syndrome (Orthodromic AV 
Reciprocating Tachycardia) 
From ref. [29] 
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Appendix 
 62
 
Normal neonatal ECG standards.  
From ref. [20] 
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Genetic defects in arrhythmic syndromes: LQTS and Brugada syndrome 
From ref.[72] modified 
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Back to sleep  
 Place your baby on the back to sleep. 
 Don't put the baby prone. 
Don't make him smoke  
 Cut out smoking during pregnancy - fathers too. 
 Don't let anyone smoke in the same room as your baby.  
Cold is better 
 Don't let your baby get too hot (or too cold) . 
 Don't worry if baby's hands or feet feel cool, this is normal. 
 Babies do not need hot rooms, all night heating is rarely 
necessary. Keep the room at a temperature that is comfortable 
for you. About 18°C (65°F) is comfortable. 
In same room !!!  
 The safest place for your baby to sleep is in a cot in your room 
for the first six months. 
 
 
 
Behaviors reducing the risk of SIDS  
From: http://www.sidsitalia.it/index 
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QT prolongation management flow chart 
From ref. [19] 
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ECG: Mobitz type I AV block 
 
 
 
ECG: Mobitz type II AV block (ratio 2:1) 
 
 
 
ECG: Third-degree AV block (AV dissociation) 
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ECG: Supraventricular Tachycardia 
 
 
 
 
ECG: Atrial Flutter 
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ECG: Ventricular Tachycardia 
 
 
 
ECG: Long QT syndrome 
 
 
 
ECG: Torsades de Pointes 
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ECG: Wolff-Parkinson-White syndrome  
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